WinstonWınston
Back
Akso Health logo

Akso Health

AHG
8
Software - Services · Technology
Price
$0.93
-0.09 (-8.85%)
Market Cap
$794.0M
Exchange
NASDAQ
Winston Score
8
Winston is worried
Weak fundamentals across most pillars.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Weak
Growth
Weak
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count rising — dilution

+10811.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 6.6M (2022) → 722.7M (2026)

Winston Score History

The full picture

Akso Health Group is a small Chinese company that has shifted its business focus several times over the years. It has operated in areas including online lending services, electric vehicles, and more recently health-related services and products. The company primarily targets consumers in China and has struggled to establish a clear, stable core business.

Akso Health generates revenue through service fees and product sales, but its financials show serious strain — a gross margin near zero and a deeply negative operating margin signal that the company spends far more than it earns. It is a micro-cap firm with a market value around $100 million, listed on a US exchange but operating mainly in China. The company faces significant risks including regulatory pressure in China, a lack of a durable competitive advantage, and a history of frequent business pivots that make its long-term direction difficult to assess.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-12.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+85.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (15%)

Research and development spending

Insider Activity

1.0%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$170,572 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Akso Health has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
-0.1%
Thin — -0.1% gross margin
Profit after running costs
Operating Margin
-28.9%
Losing money on operations — -28.9%
Return on the money invested
ROCE
-2.2%
Weak — -2.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-6.4%
Shrinking sales (-6.4% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-1362.5%
Burning cash (-1362.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.00
Conservative — low debt load (0.00)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial